Susquehanna International Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5M | Buy |
769,945
+478,929
| +165% | +$23.3M | 0.01% | 249 |
|
|
2025
Q1 | $9.9M | Sell |
291,016
-97,299
| -25% | -$3.31M | ﹤0.01% | 651 |
|
|
2024
Q4 | $15.3M | Buy |
388,315
+29,412
| +8% | +$1.16M | ﹤0.01% | 541 |
|
|
2024
Q3 | $16.9M | Buy |
358,903
+98,082
| +38% | +$4.61M | ﹤0.01% | 427 |
|
|
2024
Q2 | $14.1M | Buy |
260,821
+187,583
| +256% | +$10.1M | ﹤0.01% | 516 |
|
|
2024
Q1 | $4.99M | Sell |
73,238
-143,858
| -66% | -$9.81M | ﹤0.01% | 1027 |
|
|
2023
Q4 | $13.6M | Buy |
217,096
+34,531
| +19% | +$2.16M | ﹤0.01% | 552 |
|
|
2023
Q3 | $8.29M | Buy |
182,565
+18,846
| +12% | +$855K | ﹤0.01% | 783 |
|
|
2023
Q2 | $9.19M | Sell |
163,719
-133,070
| -45% | -$7.47M | ﹤0.01% | 738 |
|
|
2023
Q1 | $13.4M | Buy |
296,789
+214,882
| +262% | +$9.72M | ﹤0.01% | 609 |
|
|
2022
Q4 | $3.33M | Buy |
81,907
+40,084
| +96% | +$1.63M | ﹤0.01% | 1210 |
|
|
2022
Q3 | $2.73M | Buy |
41,823
+5,006
| +14% | +$327K | ﹤0.01% | 1354 |
|
|
2022
Q2 | $2.24M | Sell |
36,817
-207,914
| -85% | -$12.6M | ﹤0.01% | 1557 |
|
|
2022
Q1 | $15.4M | Sell |
244,731
-331,716
| -58% | -$20.8M | ﹤0.01% | 516 |
|
|
2021
Q4 | $43.7M | Buy |
576,447
+173,303
| +43% | +$13.1M | 0.01% | 250 |
|
|
2021
Q3 | $45.1M | Buy |
403,144
+50,971
| +14% | +$5.71M | 0.01% | 256 |
|
|
2021
Q2 | $57M | Sell |
352,173
-96,716
| -22% | -$15.7M | 0.01% | 232 |
|
|
2021
Q1 | $54.7M | Buy |
448,889
+282,629
| +170% | +$34.4M | 0.01% | 215 |
|
|
2020
Q4 | $25.5M | Buy |
166,260
+87,299
| +111% | +$13.4M | ﹤0.01% | 344 |
|
|
2020
Q3 | $6.6M | Sell |
78,961
-105,081
| -57% | -$8.79M | ﹤0.01% | 715 |
|
|
2020
Q2 | $13.5M | Sell |
184,042
-19,955
| -10% | -$1.47M | ﹤0.01% | 422 |
|
|
2020
Q1 | $8.65M | Buy |
203,997
+6,396
| +3% | +$271K | ﹤0.01% | 465 |
|
|
2019
Q4 | $12M | Buy |
197,601
+75,631
| +62% | +$4.61M | ﹤0.01% | 458 |
|
|
2019
Q3 | $5M | Sell |
121,970
-60,477
| -33% | -$2.48M | ﹤0.01% | 661 |
|
|
2019
Q2 | $8.59M | Sell |
182,447
-9,211
| -5% | -$434K | ﹤0.01% | 442 |
|
|
2019
Q1 | $6.85M | Sell |
191,658
-13,357
| -7% | -$477K | ﹤0.01% | 348 |
|
|
2018
Q4 | $5.86M | Sell |
205,015
-131,945
| -39% | -$3.77M | ﹤0.01% | 441 |
|
|
2018
Q3 | $14.9M | Buy |
336,960
+147,022
| +77% | +$6.52M | ﹤0.01% | 274 |
|
|
2018
Q2 | $11.2M | Buy |
189,938
+32,748
| +21% | +$1.92M | ﹤0.01% | 345 |
|
|
2018
Q1 | $7.19M | Buy |
157,190
+126,589
| +414% | +$5.79M | ﹤0.01% | 391 |
|
|
2017
Q4 | $719K | Buy |
30,601
+6,278
| +26% | +$148K | ﹤0.01% | 2073 |
|
|
2017
Q3 | $435K | Buy |
+24,323
| New | +$435K | ﹤0.01% | 2244 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3644 |
|